Global collaboration leads to long-awaited innovation in perfusion

Innovation in the cardiopulmonary space is critical to the delivery of high-quality care to patients. While there have been noteworthy innovations in cardiovascular surgery in recent decades, there has been a need to elevate perfusion to drive greater efficiency, better intuition, improve support to perfusionists and improve surgical outcomes through patient-centred technology.

LivaNova, a market-leading medical technology and innovation company, has launched the Essenz™ Perfusion System in Australia following a broader rollout in other markets.

The entry of the Essenz Perfusion System into the Australian market signifies a historical milestone for LivaNova, who have been producing and servicing some of the world’s most successful heart-lung machines (HLMs) for the last four decades.

Alison Horton, Perfusion Manager at The Royal Melbourne Hospital, believes the new system represents innovation that supports better patient outcomes.

“Heart-lung machines are an indispensable part of cardiac surgery. Having innovative technology like the Essenz Perfusion System helps to unlock the potential of individualised care. We are excited to see Australia continue to set high standards in cardiac care,” said Ms Horton.

The Essenz Perfusion System is the result of a comprehensive user-centric design that puts the perfusionist at the heart of each step of the design, development, and deployment process to address and anticipate the needs of the New Era of Perfusion.

According to Richard Newland, Senior Perfusionist at Flinders Medical Centre, it is encouraging to see that manufacturers are becoming increasingly aware of the importance of human factors in the design of HLMs and want to prioritise what is important to perfusionists.

“This new perfusion system is based on decades of trusted partnership and collaboration with hundreds of perfusionists globally who participated and shared feedback during every step of design and development. This simple, yet effective approach to innovation ensures that any perfusionist, whether they have been part of that process or not, will benefit from its modifications. For me it’s about the centralisation of information to avoid duplication and information overload, and this new system has taken this into account,” said Mr Newland.

The next-generation perfusion system bridges decades of proven performance with an enduring commitment to the safety of the patient and data accuracy. The latest system is rooted in data-driven decisions that improve clinical workflows and quality of patient care during cardiopulmonary bypass (CPB) procedures.

It is built on proven LivaNova S5 HLM’s reliability, with state-of-the-art safety precautions on both hardware and software. Each pump on Essenz is controlled individually for simple, straightforward operations. The Essenz HLM cockpit and Essenz Patient Monitor are connected but operate separately to further ensure reliability.

The Essenz Patient Monitor offers an intuitive user interface and continuously records and displays data and events together to assist the perfusionist throughout a procedure. Data is automatically and seamlessly transferred, minimising manual data entry and freeing up valuable time for the perfusionist.

It can be adapted to the individual needs of patients (adult and paediatric), workflows and users. It features an ergonomic design, including advanced cable management and a mast-mounted design that minimizes distractions and keeps the area clean and hygienic. The innovative cockpit provides one central view to control the device and check all perfusion and patient parameters.

The Essenz Perfusion System is backed by a responsive service team of dedicated, local engineers in more than 100 countries, along with a global support centre to address any needs.

Learn more about the entire Essenz Perfusion System on the LivaNova website: https://www.livanova.com/cardiopulmonary/en-us/essenz

^{Heart-Lung Machine}

^{EU: Devices are intended to perform, control, monitor and support extracorporeal blood circulation replacing the mechanical pumping function of the heart, monitoring and regulating physiologic parameters during procedures requiring extracorporeal circulation.}

^{Essenz Patient Monitor}

^{The Essenz Patient Monitor software is a modularly structured software program package that is exclusively used with LivaNova heart-lung machines. The system allows detailed recording of perfusion data during cardiopulmonary bypass procedures. The data may be recorded automatically or entered manually. The LivaNova Perfusion System Monitor is a panel PC intended to be exclusively used with LivaNova heart lung machines as a base and user interface for the Essenz Patient Monitor software.}

^{CONTRAINDICATIONS: No contraindications are known if the devices are used for the purpose described and in accordance with the stated operating conditions. Do not use the devices for any purpose other than indicated.}

^{WARNINGS: The devices must be used in accordance with the instructions for use provided. For a complete listing of warnings please refer to the Instructions for Use. Medical intervention and therapeutic procedure must not be based solely on the Essenz Patient Monitor perfusion records (reports).}

^{PRECAUTIONS: For a complete listing of precautions/cautions please refer to the Instructions for Use. The devices should be used by qualified and skilled personnel, able to follow the indications and instructions for use contained in the information provided by the manufacturer.}

^{Not approved in all geographies. Please visit the LivaNova website to receive instructions for use containing full prescribing information including indications, contraindications, warnings, precautions and adverse events.}

^{Legal Manufacturer:
LivaNova Deutschland
Lindberghstrasse 25
D-80939 Munich,
Germany}